The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells

Nature Medicine

Volumn 6, Issue 10, 2000, Pages 1121-1127

  Radkov, Stoyan A ^a   Kellam, Paul ^a   Boshoff, Chris ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; EPITOPE; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHROMATIN; EPISOME; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFORMATION; GENOME; HERPES VIRUS; KAPOSI SARCOMA; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RAT; RECEPTOR UPREGULATION; RETINOBLASTOMA; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMAL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN E; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; GENES, MYB; GENES, RAS; HUMAN; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RATS; RETINOBLASTOMA PROTEIN; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS;

EID: 0033782793     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/80459     Document Type: Article

References (45)

1. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
2. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
3. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
4. HHV-8 is associated with a plasmablastic variant of Castleman's disease that is linked to HHV-8 positive plasmablastic lymphoma
5. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells
6. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
7. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells
8. Distribution of HHV-8 positive cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
9. Cellular tropism and viral interleukin-6 expresion distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
10. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease
11. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
12. Establishment of a KSHV positive cell line (BCP-1) from peripheral blood and characterizing its growth in vivo
13. Infection of primary dermal microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus
14. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
15. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8
16. Association between an ancogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product
17. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
18. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
19. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product
20. The 222-234 kd nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf 73 and a component of the latency-associated nuclear antigen
21. Identification of a major latent nuclear antigen (LNA-1) in the human herpesvirus 8 (HHV-8)genome
22. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus
23. Characterising monoclonal antibodies against KSHV latent nuclear antigen (LNA-1)
24. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
25. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-asociated herpesvirus genome to host chromosomes in body-cavity-based lymphoma cells
26. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
27. Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor
28. Deregulation of cyclin E in breast cancer
29. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex
30. Prb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
31. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts
32. HPV16 E7 oncoprotein deregulates B-myb expression: Correlation with targeting of p107/E2F complexes
33. Regulation of retinoblatoma functions by ectopic expression of human cyclins
34. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
35. Cyclin encoded by KS herpesvirus
36. Development of a bioassay for human myeloma colony-forming cells
37. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signalling pathway
38. Kaposi's sarcoma associated herpesvirus (KSHV/HHV-8) G protein-coupled receptor is a viral oncogene and angiogenesis activator
39. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus
40. P53 Inhibition by LANA protein of KSHV protects against cell death
41. Interactions between SV40 large-tumor antigen and the growth suppresor proteins pRb and p53
42. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes
43. Coupling herpesvirus to angiogenesis: Viral pirates on a cellular sea
44. Transformation of rat cells by an altered polyomavirus genome expressing only the middle-T protein
45. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21